Navigation Links
Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
Date:4/17/2009

Pharmacyclics to maintain all US Rights

Conference Call to discuss the company's third quarter financial results is scheduled for April 23, 2009 at 11:00 a.m. EDT (8:00 a.m. PDT).

SUNNYVALE, Calif., April 17 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that it has entered into a global strategic alliance with Servier, the leading French independent pharmaceutical company. The alliance will focus on the research, development, and commercialization of Pharmacyclics' PCI-24781, an orally active, novel, small molecule inhibitor of Pan HDAC enzymes, that is currently in Phase I/II clinical trials in the United States and being developed for the treatment of solid tumors and hematologic malignancies. Pharmacyclics expects that this alliance will enable it to aggressively pursue its goal of developing and commercializing its innovative anti-cancer Pan HDAC inhibitor agents.

"This alliance with Servier allows us to accelerate our productive discovery efforts, to expand our clinical development capabilities and potentially commercialize our unique and differentiated Pan HDAC inhibitor product outside of the United States in rapid fashion," said Robert W. Duggan, Chairman and Chief Executive Officer of Pharmacyclics. "We are honored to be partnering with the Servier Company, they are incredibly professional in all aspects of their business dealings. Their success and advancement of human healthcare is respected around the world."

Under the terms of the agreement, Servier acquired the exclusive right to develop and commercialize the Pan HDAC inhibitor product worldwide except for the United States and will pay a royalty to Pharmacyclics on sales outside of the United States. Pharmacyclics will continue to own all rights within the United States. Pharmacyclics will re
'/>"/>

SOURCE Pharmacyclics, Inc.

http://www.pharmacyclics.com

SOURCE Pharmacyclics
Copyright©2009 PR Newswire.
All rights reserved


Page: 1 2 3 4 5

Related medicine technology :

1. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
2. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
3. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
4. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
5. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
6. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
7. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
8. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
9. Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting
10. Premier Research Announces Milestone Investigational New Drug Application
11. PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... -- The number of people overdosing from opioid prescription ... percent of the workforce has misused prescription painkillers, according ... making opioid use a serious threat to employee safety. ... correct dosage with a valid prescription, subtle impairment may ... Safety Council released a guide for employers, ...
(Date:7/22/2014)... July 22, 2014 BiologicTx ® today ... first 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx,s ... on July 9 at the Miami Transplant Institute, located ... Kidney Paired Donation (KPD) ... compatible for kidney transplant with one another due to ...
(Date:7/22/2014)... -- Elekta (NSE:EKTAb) and Royal Philips (NYSE: ... Trust ( Manchester, UK ), a specialist ... to develop the clinical value of an integrated magnetic ... system would, in principle, improve the practice of radiotherapy ... "The Christie was an essential participant in the project ...
Breaking Medicine Technology:5 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4
... Lilly and Company (NYSE: LLY ) announced ... Lilly to access innovation being developed outside the company,s ... independent venture capital firms participating in the Mirror Portfolio ... stage of their development. The first is a molecule ...
... 2011 Mylan Inc. (Nasdaq: MYL ) ... launched Voriconazole Tablets, 50 mg and 200 mg, under ... Inc. Mylan was the first company to have filed ... for Voriconazole Tablets and was awarded 180 days of ...
Cached Medicine Technology:Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 2Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 3Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines 4
(Date:7/22/2014)... 2014 Two individuals from Meditec, a ... Association for Healthcare Documentation Integrity (AHDI) Awards. One nominee ... the sole nominee for both the Excellence in Credentialing ... Linda Curia, is also nominated for the Rising Star ... field for over 18 years in a wide-variety of ...
(Date:7/22/2014)... NY (PRWEB) July 22, 2014 As ... Icahn School of Medicine at Mount Sinai have helped ... with the risk of developing schizophrenia, in the largest ... conducted with 80,000 people. The findings, published online in ... underlie schizophrenia, and could lead to new approaches to ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 University ... officially opened the doors of its state-of-the-art, $151 ... in the heart of downtown San Francisco's South of ... 10,000 patients a year. Those patients will now be ... sophisticated iKiosks . , Advanced Kiosks engineering ...
(Date:7/22/2014)... 22, 2014 (HealthDay News) -- Genetic fragments of the deadly ... where an infected camel was kept, a new study says. ... determine if Middle East Respiratory Syndrome (MERS) can be transmitted ... samples over three consecutive days from a camel barn owned ... the town of Jeddah, Saudi Arabia. The man later died. ...
(Date:7/22/2014)... electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), ... Like antidepressant medications, however, they typically have a ... several weeks of regular ECT treatments before a ... an impetus to develop antidepressant treatments that act ... (LFMS) is one such potential new treatment with ...
Breaking Medicine News(10 mins):Health News:Meditec Instructor and Student Nominated in Prestigious Medical Transcription Profession Awards 2Health News:Meditec Instructor and Student Nominated in Prestigious Medical Transcription Profession Awards 3Health News:Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date 2Health News:Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date 3Health News:Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date 4Health News:iKiosks Are Gateway to Premier Dental Facility 2Health News:iKiosks Are Gateway to Premier Dental Facility 3Health News:MERS Virus Found in Air in Camel Barn 2Health News:Low strength brain stimulation may be effective for depression 2
... pleased to announce the appointment of Dr. Elisa J. Zinberg as ... effective immediately. , ... Rye, NY (PRWEB) September 23, ... Elisa J. Zinberg as Vice - President of Operations, and member ...
... The ALS Association,s comprehensive Assistive Technology Consultation Program. The program ... ALS, also known as Lou Gehrig,s Disease, and training on available ... at the Associaton,s Chapters and Certified Centers of Excellence. , ... ...
... Coinstar Centers(R) at retail locations,nationwide, WASHINGTON, Sept. 22 ... to those affected by the recent,hurricanes by donating their ... retail locations. Simply select the Red Cross Disaster Relief ... Cross to provide immediate,food, shelter, counseling and other assistance ...
... Reasons for slowed time to treatment remain unclear, experts say ... including those on Medicaid, are more likely to take much ... strikes compared to more affluent people, a new study finds. ... at a greater risk of missing a critical window for ...
... SACRAMENTO, Calif., Sept. 22 The California Office of,Traffic Safety ... riding in car safety seats. The 2008 rate of 94.4 ... a big jump of 6.7,percentage points over the 2007 rate ... time to kick off the national Child,Passenger Safety Week, September ...
... model, it appears that comparing the benefits and risks ... and their physicians choose appropriate screening strategies, according to ... Archives of Internal Medicine , one of the JAMA/Archives ... known as Pap smears, is credited with reducing the ...
Cached Medicine News:Health News:Curemark Appoints Dr. Elisa J. Zinberg as Vice President of Operations 2Health News:DynaVox Sponsors The ALS Association's Assistive Technology Consultation Program 2Health News:DynaVox Sponsors The ALS Association's Assistive Technology Consultation Program 3Health News:Americans Urged to Support American Red Cross Disaster Relief Efforts for Hurricanes of 2008 2Health News:Heart Attack Care Often Delayed for the Poor 2Health News:Heart Attack Care Often Delayed for the Poor 3Health News:Record Upsurge in State's Child Safety Seat Usage Marks Child Passenger Safety Week 2Health News:Model highlights benefits and risks of cervical cancer screening methods 2
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
96-Well PCR Plate Sealing Mat...
Inquire...
Inquire...
Medicine Products: